Novel GII.12 norovirus strain, United States, 2009-2010

Emerging Infectious Diseases

Volumn 17, Issue 8, 2011, Pages 1516-1518

  Vega, Everardo ^a   Vinjé, Jan ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; NONHUMAN; NOROVIRUS; NUCLEOTIDE SEQUENCE; PHYLOGENY; SEQUENCE ANALYSIS; UNITED STATES; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS STRAIN; WINTER;

BASE SEQUENCE; CALICIVIRIDAE INFECTIONS; CAPSID PROTEINS; DISEASE OUTBREAKS; GENOTYPE; HUMANS; MOLECULAR SEQUENCE DATA; NOROVIRUS; PHYLOGENY; RECOMBINATION, GENETIC; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; UNITED STATES;

EID: 79960855371     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1708.110025     Document Type: Article

References (12)

1. Widdowson MA, Sulka A, Bulens SN, Beard RS, Chaves SS, Hammond R, et al. Norovirus and foodborne disease, United States, 1991-2000. Emerg Infect Dis. 2005;11:95-102.
2. Blanton LH, Adams SM, Beard RS, Wei G, Bulens SN, Widdowson MA, et al. Molecular and epidemiologic trends of caliciviruses associated with outbreaks of acute gastroenteritis in the United States, 2000-2004. J Infect Dis. 2006;193:413-21. doi:10.1086/499315
3. Bok K, Abente EJ, Realpe-Quintero M, Mitra T, Sosnovtsev SV, Kapikian AZ, et al. Evolutionary dynamics of GII.4 noroviruses over a 34-year period. J Virol. 2009;83:11890-901. doi:10.1128/ JVI.00864-09
4. Cannon JL, Lindesmith LC, Donaldson EF, Saxe L, Baric RS, Vinjé J. Herd immunity to GII.4 noroviruses is supported by outbreak patient sera. J Virol. 2009;83:5363-74. doi:10.1128/JVI.02518-08
5. Vinjé J, Hamidjaja RA, Sobsey MD. Development and application of a capsid VP1 (region D) based reverse transcription PCR assay for genotyping of genogroup I and GII noroviruses. J Virol Methods. 2004;116:109-17. doi:10.1016/j.jviromet.2003.11.001
6. Vega E, Barclay L, Gregoricus N, Willimas K, Lee D, Vinjé J. Novel surveillance network for norovirus gastroenteritis outbreaks. Emerg Infect Dis. 2011;17. In press.
7. Eden JS, Bull RA, Tu E, McIver CJ, Lyon MJ, Marshall JA, et al. Norovirus GII.4 variant 2006b caused epidemics of acute gastroenteritis in Australia during 2007 and 2008. J Clin Virol. 2010;49:265-71. doi:10.1016/j.jcv.2010.09.001
8. Bull RA, Eden JS, Rawlinson WD, White PA. Rapid evolution of pandemic noroviruses of the GGII.4 lineage. PLoS Pathog. 2010;6:e1000831. doi:10.1371/journal.ppat.1000831
9. Siebenga JJ, Vennema H, Renckens B, de Bruin E, van der Veer B, Siezen RJ, et al. Epochal evolution of GGII.4 norovirus capsid proteins from 1995 to 2006. J Virol. 2007;81:9932-41. doi:10.1128/ JVI.00674-07
10. Lindesmith LC, Donaldson EF, Lobue AD, Cannon JL, Zheng DP, Vinje J, et al. Mechanisms of GII.4 norovirus persistence in human populations. PLoS Med. 2008;5:e31. doi:10.1371/journal. pmed.0050031
11. Takanashi S, Wang Q, Chen N, Shen Q, Jung K, Zhang Z, et al. Characterization of emerging GII.g/GII.12 norovirus from a gastroenteritis outbreak in the US in 2010. J Clin Microbiol. In press.
12. Siebenga JJ, Lemey P, Pond SLK, Rambaut A, Vennema H, Koopmans M. Phylodynamic reconstruction reveals norovirus GGII.4 epidemic expansions and their molecular determinants. PLoS Pathog. 2010;6: e1000884. doi:10.1371/journal.ppat.1000884